Ultimately, identifying causative variants in JEB‐PA, as well as in EB, is crucial not only for patients and their families for diagnosis and surveillance programs but also for expanding our understanding of ITGB4, potentially leading to future therapeutic approaches. The gene discussed is ITGB4; the disease is epidermolysis bullosa.